| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2803105801071 | 310580107 | FLUOXETINE/MYLAN CAPS 20MG/CAP BTx28 (BLISTER) | 4.96 | 5.20 | 7.17 |
| 05/2018 | 2803105802092 | 310580209 | FLUOXETINE/MYLAN DISP.TAB 20MG/TAB BTx28 σε PVC/PE/PVDC AL BLISTERS PVC/PE/PVDC AL BLISTERS | 4.91 | 5.15 | 7.10 |
For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.
Metabolized to norfluoxetine, fluoxetine is a selective serotonin-reuptake inhibitor (SSRI), it blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors. SSRIs bind with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs.
Symptoms of overdose include agitation, restlessness, hypomania, and other signs of CNS excitation. LD<sub>50</sub>=284mg/kg (orally in mice).
72%
1 to 3 days
The primary route of elimination appears to be hepatic metabolism to inactive metabolites excreted by the kidney.